Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Neuron|July 15, 2019
TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's DiseaseAna Griciuc, Shaun Patel, Anthony N Federico, et al.
Pharmacoeconomics|May 27, 1999
The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on CostsE J Beck, K Tolley, A Power, et al.
Nature Communications|November 14, 2022
Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignanciesLucy B Cook, Gillian O'Dell, Eleni Vourvou, et al.
Neuroimage|March 3, 2023
Investigating Intra-Individual Networks of Response Inhibition and Interference Resolution using 7T MRIS J S Isherwood, P L Bazin, S Miletić, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 14, 2018
Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignanciesJulie Beckerson, Richard M Szydlo, Mary Hickson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2020
Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant OrganismsRohma Ghani, Benjamin H Mullish, Julie A K McDonald, et al.
Bone Marrow Transplantation|May 21, 2013
Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCTA J Innes, R Beattie, R Sergeant, et al.
Trials|April 13, 2021
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trialNikhil Vergis, Rachel Phillips, Victoria Cornelius, et al.
BMJ Open|January 8, 2025
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trialBenjamin H Mullish, Andrew J Innes, Lauren A Roberts, et al.
Nature Aging|November 28, 2022
3-deazaadenosine (3DA) alleviates senescence to promote cellular fitness and cell therapy efficiency in miceAna Guerrero, Andrew J Innes, Pierre-François Roux, et al.
Pageof 19